加载中
NASDAQHealthcareBiotechnology
最新数据
US$0.2571
+US$0.0031 · +1.22%
Enlivex Therapeutics Ltd., established in 2005 and based in Nes Ziona, Israel, operates as a clinical-stage biotechnology firm dedicated to macrophage reprogramming immunotherapy. The company is currently advancing Allocetra, its flagship cell-based therapeutic. This treatment is undergoing Phase II clinical evaluation for its effectiveness in addressing organ dysfunction and failure that arises from sepsis. Additionally, Allocetra is being investigated in preclinical studies for its potential application in solid tumor therapy.
常规交易时段
US$0.2571
+US$0.0031 · +1.22%
盘中时间采用ET。市场数据可能有所延迟。
Enlivex Therapeutics Ltd., established in 2005 and based in Nes Ziona, Israel, operates as a clinical-stage biotechnology firm dedicated to macrophage reprogramming immunotherapy. The company is currently advancing Allocetra, its flagship cell-based therapeutic. This treatment is undergoing Phase II clinical evaluation for its effectiveness in addressing organ dysfunction and failure that arises from sepsis. Additionally, Allocetra is being investigated in preclinical studies for its potential application in solid tumor therapy.
日内区间
当前US$0.2571
52周区间
当前US$0.2571
盘中时间采用ET。市场数据可能有所延迟。
Enlivex Therapeutics Ltd., established in 2005 and based in Nes Ziona, Israel, operates as a clinical-stage biotechnology firm dedicated to macrophage reprogramming immunotherapy. The company is currently advancing Allocetra, its flagship cell-based therapeutic. This treatment is undergoing Phase II clinical evaluation for its effectiveness in addressing organ dysfunction and failure that arises from sepsis. Additionally, Allocetra is being investigated in preclinical studies for its potential application in solid tumor therapy.
日内区间
当前US$0.2571
52周区间
当前US$0.2571
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$15.00
上涨空间 5734.31%评级样本有限，仅4项
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2026年7月9日 | 1:15 | — | — |
股票拆分 | 2019年3月6日 | 1:8 | — | — |
股票拆分 | 2017年9月25日 | 1:5 | — | — |
已生效 2026年7月9日
1:15
已生效 2019年3月6日
1:8
已生效 2017年9月25日
1:5
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
